189 related articles for article (PubMed ID: 30367334)
1. Comparison of Monitor-Image and Printout-Image Methods in Ki-67 Scoring of Gastroenteropancreatic Neuroendocrine Tumors.
Dogukan FM; Yilmaz Ozguven B; Dogukan R; Kabukcuoglu F
Endocr Pathol; 2019 Mar; 30(1):17-23. PubMed ID: 30367334
[TBL] [Abstract][Full Text] [Related]
2. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study.
Shi H; Zhang Q; Han C; Zhen D; Lin R
BMC Endocr Disord; 2018 Jul; 18(1):51. PubMed ID: 30055596
[TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin.
Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M
Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757
[TBL] [Abstract][Full Text] [Related]
4. Gastroenteropancreatic grade 3 neuroendocrine tumors: a single entity or a heterogeneous group? A retrospective analysis.
Laffi A; Spada F; Bagnardi V; Frassoni S; Pisa E; Rubino M; Barberis M; Fazio N
J Endocrinol Invest; 2022 Feb; 45(2):317-325. PubMed ID: 34282554
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): what's better?
Milione M
Endocrine; 2018 Jan; 59(1):1-3. PubMed ID: 28417314
[No Abstract] [Full Text] [Related]
6. Ki-67 proliferation index in neuroendocrine tumors: Can augmented reality microscopy with image analysis improve scoring?
Satturwar SP; Pantanowitz JL; Manko CD; Seigh L; Monaco SE; Pantanowitz L
Cancer Cytopathol; 2020 Aug; 128(8):535-544. PubMed ID: 32401429
[TBL] [Abstract][Full Text] [Related]
7. Recent updates on grading and classification of neuroendocrine tumors.
Kim JY; Hong SM; Ro JY
Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
[TBL] [Abstract][Full Text] [Related]
8. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors.
Kroneman TN; Voss JS; Lohse CM; Wu TT; Smyrk TC; Zhang L
Endocr Pathol; 2015 Sep; 26(3):255-62. PubMed ID: 26072124
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of visual assessments of proliferation indices in gastroenteropancreatic neuroendocrine tumours.
Young HT; Carr NJ; Green B; Tilley C; Bhargava V; Pearce N
J Clin Pathol; 2013 Aug; 66(8):700-4. PubMed ID: 23703851
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an Image-based Automated Detection System in Detecting Ki67 Proliferation Index and Correlation with the Traditional Eye-Ball Method in Gastroenteropancreatic Neuroendocrine Tumors.
Dere Y; Ozkaraca O; Cetin G; Dere O
J Coll Physicians Surg Pak; 2019 Feb; 29(2):137-140. PubMed ID: 30700352
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 Proliferation Index Assessment in Gastroenteropancreatic Neuroendocrine Tumors by Digital Image Analysis With Stringent Case and Hotspot Level Concordance Requirements.
Boukhar SA; Gosse MD; Bellizzi AM; Rajan K D A
Am J Clin Pathol; 2021 Sep; 156(4):607-619. PubMed ID: 33847759
[TBL] [Abstract][Full Text] [Related]
13. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
14. Grade Assignment by Ki-67 Proliferative Index, Mitotic Count, and Phosphohistone H3 Count in Surgically Resected Gastrointestinal and Pancreatic Neuroendocrine Tumors.
Murphy CE; McCormick KA; Shankaran V; Reddi DM; Swanson PE; Upton MP; Papanicolau-Sengos A; Khor S; Westerhoff M
Pancreas; 2017; 46(10):1359-1365. PubMed ID: 29040195
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 Labeling Index Variability Between Surgically Resected Primary and Metastatic Hepatic Lesions of Gastroenteropancreatic Neuroendocrine Neoplasms.
Furukawa T; Ozaka M; Takamatsu M; Takazawa Y; Inamura K; Inoue Y; Mie T; Takeda T; Kanata R; Kasuga A; Matsuyama M; Sasaki T; Takahashi Y; Sasahira N
Int J Surg Pathol; 2021 Aug; 29(5):475-481. PubMed ID: 33543658
[No Abstract] [Full Text] [Related]
16. Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor.
Grillo F; Albertelli M; Brisigotti MP; Borra T; Boschetti M; Fiocca R; Ferone D; Mastracci L
Neuroendocrinology; 2016; 103(5):452-9. PubMed ID: 26337010
[TBL] [Abstract][Full Text] [Related]
17. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index.
Lea D; Gudlaugsson EG; Skaland I; Lillesand M; Søreide K; Søreide JA
Appl Immunohistochem Mol Morphol; 2021 Aug; 29(7):499-505. PubMed ID: 33758143
[TBL] [Abstract][Full Text] [Related]
18. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods.
Tang LH; Gonen M; Hedvat C; Modlin IM; Klimstra DS
Am J Surg Pathol; 2012 Dec; 36(12):1761-70. PubMed ID: 23026928
[TBL] [Abstract][Full Text] [Related]
19. KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?
Grillo F; Valle L; Ferone D; Albertelli M; Brisigotti MP; Cittadini G; Vanoli A; Fiocca R; Mastracci L
Endocrine; 2017 Sep; 57(3):494-502. PubMed ID: 28726181
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis.
Owens R; Gilmore E; Bingham V; Cardwell C; McBride H; McQuaid S; Humphries M; Kelly P
Histopathology; 2020 Oct; 77(4):646-658. PubMed ID: 32617996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
